CMV-enAsCas12f Citations (1)

Originally described in: An engineered hypercompact CRISPR-Cas12f system with boosted gene-editing activity.
Wu T, Liu C, Zou S, Lyu R, Yang B, Yan H, Zhao M, Tang W Nat Chem Biol. 2023 Jul 3. doi: 10.1038/s41589-023-01380-9. PubMed Journal

---

Articles Citing CMV-enAsCas12f

Articles
Noncanonical target-strand cytosine base editing via engineered Un1Cas12f1 platform. Song Z, Guo J, Fan Z, Huang S, Li G, Zhao Z, Chen B, Huang S, Zheng W, Wei Y, Chen Y, Huang X, Liu J, Wu L, Wang X. Nat Commun. 2025 Oct 28;16(1):9499. doi: 10.1038/s41467-025-64562-0. PubMed

If you have published an article using this material, please email us at to have your article added to this page.